0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.

      Biochimica et Biophysica Acta
      Complement Activating Enzymes, antagonists & inhibitors, Complement C1 Inactivator Proteins, Complement C1r, Enzyme Precursors, Fibrinolysin, Guanidines, pharmacology, Humans, Kallikreins, Protease Inhibitors, Thrombin, Trypsin Inhibitors

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          p-Guanidinobenzoate derivates were prepared and their inhibitory effects on trypsin, plasmin, pancreatic kallikrein, plasma kallikrein, thrombin, C1r and C1 esterase were examined. Among the various inhibitors tested, 6'-amidino-2-naphthyl-4-guanidinobenzoate dihydrochloride, 4-(beta-amidinoethenyl)phenyl-4-guanidinobenzoate dimethanesulfonate and 4-amidino-2-benzoylphenyl-4-guanidinobenzoate dimethanesulfonate were the most effective inhibitors of trypsin, plasmin, pancreatic kallikrein. plasma kallikrein and thrombin and they strongly inhibited the esterolytic activities of C1r and C1 esterase, and then strongly inhibited complement-mediated hemolysis.

          Related collections

          Author and article information

          Comments

          Comment on this article